Cargando…
索拉非尼作为挽救性治疗在难治复发性FLT3突变阳性急性髓系白血病中的临床应用研究
OBJECTIVE: To analyze the effect of sorafenib as salvage therapy used before and/or after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in refractory relapsed FLT3-positive acute myeloid leukemia (AML). METHODS: A total of 16 patients with refractory relapsed FLT3-positive AML, incl...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343102/ https://www.ncbi.nlm.nih.gov/pubmed/27093991 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.04.009 |
Ejemplares similares
-
CLAG方案联合索拉非尼治疗难治性急性髓系白血病一例
Publicado: (2015) -
索拉非尼单药治疗FLT3-ITD突变阳性急性髓系白血病14例疗效及安全性分析
Publicado: (2016) -
索拉非尼联合化疗一线治疗FLT3-ITD突变阳性急性髓系白血病的临床对照研究
Publicado: (2017) -
索拉非尼联合化疗治疗FLT3-ITD突变阳性急性髓系白血病九例报告并文献复习
Publicado: (2015) -
索拉非尼联合CHAG方案诱导治疗10例FLT3-ITD突变阳性急性髓系白血病患者疗效观察
Publicado: (2016)